NCT06856200
- Conditions
- Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine Therapy
- Locations
-
- Cancer Hospital Affiliated to Fudan University Shanghai, China
Clinical trial condition
Advanced HR - Positive, HER2 - Negative Breast Cancer
Explore clinical trials studying Advanced HR - Positive, HER2 - Negative Breast Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study